2024 Q2 Form 10-Q Financial Statement

#000162828024022619 Filed on May 10, 2024

View on sec.gov

Income Statement

Concept 2024 Q2 2024 Q1 2023 Q1
Revenue $459.7M $431.7M $390.6M
YoY Change 13.87% 10.53% 14.28%
Cost Of Revenue $343.6M $343.5M $315.6M
YoY Change 9.03% 8.82% 12.53%
Gross Profit $116.2M $88.23M $74.94M
YoY Change 31.08% 17.74% 22.28%
Gross Profit Margin 25.27% 20.44% 19.19%
Selling, General & Admin $29.90M $28.83M $28.95M
YoY Change -0.51% -0.43% -2.27%
% of Gross Profit 25.74% 32.67% 38.63%
Research & Development
YoY Change
% of Gross Profit
Depreciation & Amortization $34.48M $32.37M $31.32M
YoY Change 7.13% 3.36% 15.48%
% of Gross Profit 29.68% 36.69% 41.79%
Operating Expenses $424.9M $420.4M $383.9M
YoY Change 12.02% 9.5% 11.76%
Operating Profit $34.85M $11.34M $6.671M
YoY Change 42.57% 69.97% -488.07%
Interest Expense -$24.58M -$10.73M -$18.39M
YoY Change 135.09% -41.66% -256.58%
% of Operating Profit -70.55% -94.6% -275.63%
Other Income/Expense, Net -$25.45M -$7.793M -$19.82M
YoY Change 142.4% -60.68% -271.18%
Pretax Income $9.401M $3.546M -$13.15M
YoY Change -32.58% -126.97% -233.36%
Income Tax $2.500M -$1.900M $1.100M
% Of Pretax Income 26.59% -53.58%
Net Earnings -$2.982M -$2.779M -$21.01M
YoY Change -135.63% -86.77% -797.15%
Net Earnings / Revenue -0.65% -0.64% -5.38%
Basic Earnings Per Share -$0.04 -$0.04 -$0.36
Diluted Earnings Per Share -$0.04 -$0.04 -$0.36
COMMON SHARES
Basic Shares Outstanding 73.88M shares 68.48M shares 57.84M shares
Diluted Shares Outstanding 73.42M shares 69.31M shares 57.70M shares

Balance Sheet

Concept 2024 Q2 2024 Q1 2023 Q1
SHORT-TERM ASSETS
Cash & Short-Term Investments $741.7M $527.0M $90.84M
YoY Change 107.96% 480.09% 28.47%
Cash & Equivalents $741.7M $527.0M $90.84M
Short-Term Investments
Other Short-Term Assets $38.54M $45.01M $55.10M
YoY Change -21.86% -18.32% 5.0%
Inventory
Prepaid Expenses
Receivables $195.3M $189.6M $176.4M
Other Receivables $0.00 $0.00 $0.00
Total Short-Term Assets $1.005B $795.8M $342.7M
YoY Change 66.71% 132.23% 18.7%
LONG-TERM ASSETS
Property, Plant & Equipment $652.9M $618.9M $545.5M
YoY Change 13.33% 13.46% 11.56%
Goodwill $709.0M $694.3M $687.1M
YoY Change 3.07% 1.05% 20.5%
Intangibles $84.05M $86.88M $103.0M
YoY Change -16.31% -15.65% 3.69%
Long-Term Investments $9.200M $9.200M $59.32M
YoY Change -82.47% -84.49% 32.57%
Other Assets $53.86M $54.98M $53.17M
YoY Change -8.04% 3.4% -1.17%
Total Long-Term Assets $2.225B $2.174B $2.071B
YoY Change 5.81% 4.94% 11.8%
TOTAL ASSETS
Total Short-Term Assets $1.005B $795.8M $342.7M
Total Long-Term Assets $2.225B $2.174B $2.071B
Total Assets $3.229B $2.970B $2.414B
YoY Change 19.37% 23.01% 12.73%
SHORT-TERM LIABILITIES
YoY Change
Accounts Payable $386.3M $345.1M $328.3M
YoY Change 9.21% 5.12% 1393.18%
Accrued Expenses $59.25M $58.14M $58.59M
YoY Change -0.43% -0.77% -9.73%
Deferred Revenue $4.462M $4.475M $4.343M
YoY Change -11.71% 3.04%
Short-Term Debt $0.00 $0.00 $0.00
YoY Change
Long-Term Debt Due $24.22M $20.20M $15.94M
YoY Change 51.45% 26.78% 42.74%
Total Short-Term Liabilities $474.2M $427.9M $407.1M
YoY Change 9.2% 5.1% 6.78%
LONG-TERM LIABILITIES
Long-Term Debt $1.002B $814.4M $852.4M
YoY Change 18.16% -4.45% 15.07%
Other Long-Term Liabilities $10.13M $5.074M $27.52M
YoY Change -55.69% -81.56% 271.88%
Total Long-Term Liabilities $1.013B $819.5M $879.9M
YoY Change 16.22% -6.86% 17.61%
TOTAL LIABILITIES
Total Short-Term Liabilities $474.2M $427.9M $407.1M
Total Long-Term Liabilities $1.013B $819.5M $879.9M
Total Liabilities $2.137B $1.892B $1.921B
YoY Change 9.89% -1.5% 11.68%
SHAREHOLDERS EQUITY
Retained Earnings -$85.34M -$82.36M -$103.6M
YoY Change -10.41% -20.53% 14.81%
Common Stock $7.000K $7.000K $6.000K
YoY Change 0.0% 16.67% 20.0%
Preferred Stock
YoY Change
Treasury Stock (at cost)
YoY Change
Treasury Stock Shares
Shareholders Equity $881.0M $873.0M $327.9M
YoY Change
Total Liabilities & Shareholders Equity $3.229B $2.970B $2.414B
YoY Change 19.37% 23.01% 12.73%

Cashflow Statement

Concept 2024 Q2 2024 Q1 2023 Q1
OPERATING ACTIVITIES
Net Income -$2.982M -$2.779M -$21.01M
YoY Change -135.63% -86.77% -797.15%
Depreciation, Depletion And Amortization $34.48M $32.37M $31.32M
YoY Change 7.13% 3.36% 15.48%
Cash From Operating Activities $116.0M $17.09M $32.62M
YoY Change 70.41% -47.62% 3519.98%
INVESTING ACTIVITIES
Capital Expenditures $46.69M $57.41M $55.92M
YoY Change 18.3% 2.67% -252.95%
Acquisitions
YoY Change
Other Investing Activities -$30.66M -$3.528M -$9.641M
YoY Change 3348.26% -63.41% -61.45%
Cash From Investing Activities -$77.34M -$60.94M -$65.56M
YoY Change 91.66% -7.05% 6.48%
FINANCING ACTIVITIES
Cash Dividend Paid
YoY Change
Common Stock Issuance & Retirement, Net
YoY Change
Debt Paid & Issued, Net
YoY Change
Cash From Financing Activities 176.1M $228.3M -$3.821M
YoY Change -26.04% -6074.82% 15.33%
NET CHANGE
Cash From Operating Activities 116.0M $17.09M $32.62M
Cash From Investing Activities -77.34M -$60.94M -$65.56M
Cash From Financing Activities 176.1M $228.3M -$3.821M
Net Change In Cash 214.8M $184.4M -$36.99M
YoY Change -19.21% -598.54% -42.11%
FREE CASH FLOW
Cash From Operating Activities $116.0M $17.09M $32.62M
Capital Expenditures $46.69M $57.41M $55.92M
Free Cash Flow $69.32M -$40.32M -$23.30M
YoY Change 142.29% 73.07% -162.2%

Facts In Submission

Frame Concept Type Concept / XBRL Key Value Unit
CY2023Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
12185000 usd
CY2024Q1 us-gaap Derivative Gain Loss Statement Of Income Or Comprehensive Income Extensible Enumeration
DerivativeGainLossStatementOfIncomeOrComprehensiveIncomeExtensibleEnumeration
http://fasb.org/us-gaap/2023#InterestExpenseDebt
CY2024Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
431707000 usd
CY2023Q1 us-gaap Revenue From Contract With Customer Excluding Assessed Tax
RevenueFromContractWithCustomerExcludingAssessedTax
390564000 usd
CY2024Q1 rdnt Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
387589000 usd
CY2023Q1 rdnt Operating Expenses Excluding Depreciation And Amortization
OperatingExpensesExcludingDepreciationAndAmortization
351865000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32368000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31315000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-186000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-579000 usd
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
225000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
134000 usd
CY2024Q1 us-gaap Operating Expenses
OperatingExpenses
420368000 usd
CY2023Q1 us-gaap Operating Expenses
OperatingExpenses
383893000 usd
CY2024Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
11339000 usd
CY2023Q1 us-gaap Operating Income Loss
OperatingIncomeLoss
6671000 usd
CY2024Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
16267000 usd
CY2023Q1 us-gaap Interest Expense Debt
InterestExpenseDebt
15722000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4324000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
1428000 usd
CY2024Q1 us-gaap Increase Decrease In Fair Value Of Hedged Item In Interest Rate Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
1216000 usd
CY2023Q1 us-gaap Increase Decrease In Fair Value Of Hedged Item In Interest Rate Fair Value Hedge1
IncreaseDecreaseInFairValueOfHedgedItemInInterestRateFairValueHedge1
-4093000 usd
CY2024Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
2934000 usd
CY2023Q1 us-gaap Other Nonoperating Income Expense
OtherNonoperatingIncomeExpense
-1432000 usd
CY2024Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-7793000 usd
CY2023Q1 us-gaap Nonoperating Income Expense
NonoperatingIncomeExpense
-19819000 usd
CY2024Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
3546000 usd
CY2023Q1 us-gaap Income Loss From Continuing Operations Before Income Taxes Extraordinary Items Noncontrolling Interest
IncomeLossFromContinuingOperationsBeforeIncomeTaxesExtraordinaryItemsNoncontrollingInterest
-13148000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1864000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1135000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5410000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-14283000 usd
CY2024Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
8189000 usd
CY2023Q1 us-gaap Net Income Loss Attributable To Noncontrolling Interest
NetIncomeLossAttributableToNoncontrollingInterest
6722000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2779000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21005000 usd
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69307078 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69307078 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57701439 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57701439 shares
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5410000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-14283000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
-2198000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Net Of Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentNetOfTax
2777000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-739000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-922000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
3951000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Including Portion Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxIncludingPortionAttributableToNoncontrollingInterest
-10584000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
8189000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax Attributable To Noncontrolling Interest
ComprehensiveIncomeNetOfTaxAttributableToNoncontrollingInterest
6722000 usd
CY2024Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-4238000 usd
CY2023Q1 us-gaap Comprehensive Income Net Of Tax
ComprehensiveIncomeNetOfTax
-17306000 usd
CY2023Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
813359000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
8000 usd
CY2024Q1 us-gaap Adjustments To Additional Paid In Capital Sharebased Compensation Requisite Service Period Recognition Value
AdjustmentsToAdditionalPaidInCapitalSharebasedCompensationRequisiteServicePeriodRecognitionValue
11906000 usd
CY2024Q1 us-gaap Stock Issued During Period Value New Issues
StockIssuedDuringPeriodValueNewIssues
218385000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Acquisitions
StockIssuedDuringPeriodValueAcquisitions
4607000 usd
CY2024Q1 us-gaap Stock Issued During Period Value Restricted Stock Award Forfeitures
StockIssuedDuringPeriodValueRestrictedStockAwardForfeitures
9000 usd
CY2024Q1 us-gaap Noncontrolling Interest Increase From Sale Of Parent Equity Interest
NoncontrollingInterestIncreaseFromSaleOfParentEquityInterest
21191000 usd
CY2024Q1 rdnt Noncontrolling Interest Increase Contribution From Noncontrolling Interest
NoncontrollingInterestIncreaseContributionFromNoncontrollingInterest
3927000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
-2198000 usd
CY2024Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-739000 usd
CY2024Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
1077325000 usd
CY2022Q4 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
491452000 usd
CY2023Q1 us-gaap Stock Issued During Period Value Stock Options Exercised
StockIssuedDuringPeriodValueStockOptionsExercised
51000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Foreign Currency Transaction And Translation Adjustment Before Tax
OtherComprehensiveIncomeLossForeignCurrencyTransactionAndTranslationAdjustmentBeforeTax
2777000 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Before Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossBeforeReclassificationAfterTax
0 usd
CY2023Q1 us-gaap Other Comprehensive Income Loss Cash Flow Hedge Gain Loss Reclassification After Tax
OtherComprehensiveIncomeLossCashFlowHedgeGainLossReclassificationAfterTax
-922000 usd
CY2023Q1 us-gaap Stockholders Equity Other
StockholdersEquityOther
3000 usd
CY2023Q1 us-gaap Profit Loss
ProfitLoss
-14283000 usd
CY2023Q1 us-gaap Stockholders Equity Including Portion Attributable To Noncontrolling Interest
StockholdersEquityIncludingPortionAttributableToNoncontrollingInterest
493101000 usd
CY2024Q1 us-gaap Profit Loss
ProfitLoss
5410000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32368000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31315000 usd
CY2024Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
14711000 usd
CY2023Q1 us-gaap Operating Lease Right Of Use Asset Amortization Expense
OperatingLeaseRightOfUseAssetAmortizationExpense
15699000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
4324000 usd
CY2023Q1 us-gaap Income Loss From Equity Method Investments Net Of Dividends Or Distributions
IncomeLossFromEquityMethodInvestmentsNetOfDividendsOrDistributions
1835000 usd
CY2024Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
748000 usd
CY2023Q1 us-gaap Amortization Of Financing Costs
AmortizationOfFinancingCosts
746000 usd
CY2024Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-186000 usd
CY2023Q1 us-gaap Gain Loss On Disposition Of Assets
GainLossOnDispositionOfAssets
-579000 usd
CY2024Q1 us-gaap Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
739000 usd
CY2023Q1 us-gaap Amortization Of Deferred Hedge Gains
AmortizationOfDeferredHedgeGains
922000 usd
CY2024Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
1216000 usd
CY2023Q1 us-gaap Unrealized Gain Loss On Derivatives
UnrealizedGainLossOnDerivatives
-4093000 usd
CY2024Q1 us-gaap Share Based Compensation
ShareBasedCompensation
11897000 usd
CY2023Q1 us-gaap Share Based Compensation
ShareBasedCompensation
12185000 usd
CY2024Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
1974000 usd
CY2023Q1 us-gaap Business Combination Contingent Consideration Arrangements Change In Amount Of Contingent Consideration Liability1
BusinessCombinationContingentConsiderationArrangementsChangeInAmountOfContingentConsiderationLiability1
2335000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
25865000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Receivable
IncreaseDecreaseInAccountsReceivable
9997000 usd
CY2024Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
6277000 usd
CY2023Q1 us-gaap Increase Decrease In Other Current Assets
IncreaseDecreaseInOtherCurrentAssets
1691000 usd
CY2024Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
5892000 usd
CY2023Q1 us-gaap Increase Decrease In Other Noncurrent Assets
IncreaseDecreaseInOtherNoncurrentAssets
2726000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
1158000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Income Taxes
IncreaseDecreaseInDeferredIncomeTaxes
-942000 usd
CY2024Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-12883000 usd
CY2023Q1 us-gaap Increase Decrease In Operating Lease Liability
IncreaseDecreaseInOperatingLeaseLiability
-15080000 usd
CY2024Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
-172000 usd
CY2023Q1 us-gaap Increase Decrease In Deferred Revenue
IncreaseDecreaseInDeferredRevenue
335000 usd
CY2024Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
6839000 usd
CY2023Q1 us-gaap Increase Decrease In Accounts Payable And Accrued Liabilities
IncreaseDecreaseInAccountsPayableAndAccruedLiabilities
9077000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
17085000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Operating Activities
NetCashProvidedByUsedInOperatingActivities
32616000 usd
CY2024Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
3530000 usd
CY2023Q1 us-gaap Payments To Acquire Buildings
PaymentsToAcquireBuildings
9644000 usd
CY2024Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
57409000 usd
CY2023Q1 us-gaap Payments To Acquire Other Property Plant And Equipment
PaymentsToAcquireOtherPropertyPlantAndEquipment
55915000 usd
CY2024Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
2000 usd
CY2023Q1 us-gaap Proceeds From Sale Of Property Plant And Equipment
ProceedsFromSaleOfPropertyPlantAndEquipment
3000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-60937000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Investing Activities
NetCashProvidedByUsedInInvestingActivities
-65556000 usd
CY2024Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
1102000 usd
CY2023Q1 us-gaap Repayments Of Notes Payable
RepaymentsOfNotesPayable
184000 usd
CY2024Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
1875000 usd
CY2023Q1 us-gaap Repayments Of Debt
RepaymentsOfDebt
3688000 usd
CY2024Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
4169000 usd
CY2023Q1 us-gaap Proceeds From Minority Shareholders
ProceedsFromMinorityShareholders
0 usd
CY2024Q1 rdnt Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary
ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary
8713000 usd
CY2023Q1 rdnt Proceeds From Sale Of Economic Interest In A Majority Owned Subsidiary
ProceedsFromSaleOfEconomicInterestInAMajorityOwnedSubsidiary
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
218385000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Common Stock
ProceedsFromIssuanceOfCommonStock
0 usd
CY2024Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
8000 usd
CY2023Q1 us-gaap Proceeds From Issuance Of Shares Under Incentive And Share Based Compensation Plans Including Stock Options
ProceedsFromIssuanceOfSharesUnderIncentiveAndShareBasedCompensationPlansIncludingStockOptions
51000 usd
CY2024Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
228298000 usd
CY2023Q1 us-gaap Net Cash Provided By Used In Financing Activities
NetCashProvidedByUsedInFinancingActivities
-3821000 usd
CY2024Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-36000 usd
CY2023Q1 us-gaap Effect Of Exchange Rate On Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
EffectOfExchangeRateOnCashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
-229000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
184410000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents Period Increase Decrease Including Exchange Rate Effect
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalentsPeriodIncreaseDecreaseIncludingExchangeRateEffect
-36990000 usd
CY2023Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
342570000 usd
CY2022Q4 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
127834000 usd
CY2024Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
526980000 usd
CY2023Q1 us-gaap Cash Cash Equivalents Restricted Cash And Restricted Cash Equivalents
CashCashEquivalentsRestrictedCashAndRestrictedCashEquivalents
90844000 usd
CY2024Q1 us-gaap Interest Paid Net
InterestPaidNet
18285000 usd
CY2023Q1 us-gaap Interest Paid Net
InterestPaidNet
21471000 usd
CY2024Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
1000 usd
CY2023Q1 us-gaap Income Taxes Paid Net
IncomeTaxesPaidNet
40000 usd
CY2024Q1 rdnt Equipment Acquired And Leasehold Improvements
EquipmentAcquiredAndLeaseholdImprovements
44100000 usd
CY2023Q1 rdnt Equipment Acquired And Leasehold Improvements
EquipmentAcquiredAndLeaseholdImprovements
40800000 usd
CY2024Q1 rdnt Number Of Centers
NumberOfCenters
375 center
CY2024Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Revenues
VariableInterestEntityActivityBetweenVIEAndEntityRevenues
52300000 usd
CY2023Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Revenues
VariableInterestEntityActivityBetweenVIEAndEntityRevenues
48800000 usd
CY2024Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
52300000 usd
CY2023Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Expense
VariableInterestEntityActivityBetweenVIEAndEntityExpense
48800000 usd
CY2024Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Income Or Loss Before Tax
VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
234800000 usd
CY2023Q1 us-gaap Variable Interest Entity Activity Between Vie And Entity Income Or Loss Before Tax
VariableInterestEntityActivityBetweenVIEAndEntityIncomeOrLossBeforeTax
207400000 usd
CY2024Q1 rdnt Contracts Receivable Factoring Receivable
ContractsReceivableFactoringReceivable
12100000 usd
CY2023Q4 rdnt Contracts Receivable Factoring Receivable
ContractsReceivableFactoringReceivable
14300000 usd
CY2024Q1 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1500000 usd
CY2023Q4 us-gaap Deferred Finance Costs Net
DeferredFinanceCostsNet
1600000 usd
CY2024Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.526
CY2024Q1 us-gaap Goodwill
Goodwill
694300000 usd
CY2023Q4 us-gaap Goodwill Impairment Loss
GoodwillImpairmentLoss
0 usd
CY2023Q4 us-gaap Goodwill
Goodwill
679463000 usd
CY2024Q1 us-gaap Goodwill Acquired During Period
GoodwillAcquiredDuringPeriod
16156000 usd
CY2024Q1 us-gaap Goodwill Foreign Currency Translation Gain Loss
GoodwillForeignCurrencyTranslationGainLoss
1327000 usd
CY2024Q1 us-gaap Goodwill Other Increase Decrease
GoodwillOtherIncreaseDecrease
0 usd
CY2024Q1 us-gaap Goodwill
Goodwill
694292000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Remainder Of Fiscal Year
FiniteLivedIntangibleAssetsAmortizationExpenseRemainderOfFiscalYear
9253000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12068000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
11619000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
10613000 usd
CY2024Q1 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10472000 usd
CY2024Q1 rdnt Finite Lived Intangible Asset Expected Amortization After Year Four
FiniteLivedIntangibleAssetExpectedAmortizationAfterYearFour
32858000 usd
CY2024Q1 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
86883000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Next Twelve Months
FiniteLivedIntangibleAssetsAmortizationExpenseNextTwelveMonths
12645000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Two
FiniteLivedIntangibleAssetsAmortizationExpenseYearTwo
12283000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Three
FiniteLivedIntangibleAssetsAmortizationExpenseYearThree
11833000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Four
FiniteLivedIntangibleAssetsAmortizationExpenseYearFour
10818000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseYearFive
10505000 usd
CY2023Q4 us-gaap Finite Lived Intangible Assets Amortization Expense After Year Five
FiniteLivedIntangibleAssetsAmortizationExpenseAfterYearFive
32531000 usd
CY2023Q4 us-gaap Intangible Assets Net Excluding Goodwill
IntangibleAssetsNetExcludingGoodwill
90615000 usd
CY2024Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3200000 usd
CY2023Q1 us-gaap Amortization Of Intangible Assets
AmortizationOfIntangibleAssets
3000000 usd
CY2024Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
-1900000 usd
CY2023Q1 us-gaap Income Tax Expense Benefit
IncomeTaxExpenseBenefit
1100000 usd
CY2023Q1 us-gaap Effective Income Tax Rate Continuing Operations
EffectiveIncomeTaxRateContinuingOperations
-0.086
CY2024Q1 rdnt Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
1 incentiveplan
rdnt Monthly Amortization Of Deferred Hedge Gains
MonthlyAmortizationOfDeferredHedgeGains
400000 usd
CY2024Q1 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
821187000 usd
CY2023Q4 us-gaap Debt Instrument Fair Value
DebtInstrumentFairValue
823063000 usd
CY2024Q1 us-gaap Net Income Loss
NetIncomeLoss
-2779000 usd
CY2023Q1 us-gaap Net Income Loss
NetIncomeLoss
-21005000 usd
CY2024Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
69307078 shares
CY2024Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
69307078 shares
CY2023Q1 us-gaap Weighted Average Number Of Shares Outstanding Basic
WeightedAverageNumberOfSharesOutstandingBasic
57701439 shares
CY2023Q1 us-gaap Weighted Average Number Of Diluted Shares Outstanding
WeightedAverageNumberOfDilutedSharesOutstanding
57701439 shares
CY2024Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.04
CY2024Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.04
CY2023Q1 us-gaap Earnings Per Share Diluted
EarningsPerShareDiluted
-0.36
CY2023Q1 us-gaap Earnings Per Share Basic
EarningsPerShareBasic
-0.36
CY2024Q1 rdnt Fair Value Change For Contingently Available Shares Excluded From Computation Of Diluted
FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
0 usd
CY2023Q1 rdnt Fair Value Change For Contingently Available Shares Excluded From Computation Of Diluted
FairValueChangeForContingentlyAvailableSharesExcludedFromComputationOfDiluted
769000 usd
CY2024Q1 rdnt Equity Securities Without Readily Determinable Fair Value Number Of Securities
EquitySecuritiesWithoutReadilyDeterminableFairValueNumberOfSecurities
4 security
CY2024Q1 us-gaap Equity Method Investments
EquityMethodInvestments
9200000 usd
CY2024Q1 rdnt Numberof Unconsolidated Joint Ventures
NumberofUnconsolidatedJointVentures
13 jointventure
CY2023Q4 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
92710000 usd
CY2024Q1 us-gaap Income Loss From Equity Method Investments
IncomeLossFromEquityMethodInvestments
4324000 usd
CY2024Q1 us-gaap Equity Method Investment Dividends Or Distributions
EquityMethodInvestmentDividendsOrDistributions
0 usd
CY2024Q1 us-gaap Investments In Affiliates Subsidiaries Associates And Joint Ventures
InvestmentsInAffiliatesSubsidiariesAssociatesAndJointVentures
97034000 usd
CY2024Q1 rdnt Management Service Fees
ManagementServiceFees
5900000 usd
CY2023Q1 rdnt Management Service Fees
ManagementServiceFees
4200000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Exercises In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsExercisesInPeriodWeightedAverageExercisePrice
6.30
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
910411 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.61
CY2024Q1 us-gaap Revenues
Revenues
431707000 usd
CY2023Q1 us-gaap Revenues
Revenues
390564000 usd
CY2024Q1 us-gaap Revenues
Revenues
431707000 usd
CY2023Q1 us-gaap Revenues
Revenues
390564000 usd
CY2024Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
387589000 usd
CY2023Q1 us-gaap Operating Costs And Expenses
OperatingCostsAndExpenses
351865000 usd
CY2024Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
32368000 usd
CY2023Q1 us-gaap Depreciation Depletion And Amortization
DepreciationDepletionAndAmortization
31315000 usd
CY2024Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-186000 usd
CY2023Q1 us-gaap Gain Loss On Sale Of Property Plant Equipment
GainLossOnSaleOfPropertyPlantEquipment
-579000 usd
CY2024Q1 us-gaap Severance Costs1
SeveranceCosts1
225000 usd
CY2023Q1 us-gaap Severance Costs1
SeveranceCosts1
134000 usd
CY2024Q1 rdnt Operating Income Loss Excluding Relief Funding
OperatingIncomeLossExcludingReliefFunding
11339000 usd
CY2023Q1 rdnt Operating Income Loss Excluding Relief Funding
OperatingIncomeLossExcludingReliefFunding
6671000 usd
CY2024Q1 us-gaap Long Term Debt
LongTermDebt
834644000 usd
CY2023Q4 us-gaap Long Term Debt
LongTermDebt
830042000 usd
CY2024Q1 us-gaap Long Term Debt Current
LongTermDebtCurrent
20202000 usd
CY2023Q4 us-gaap Long Term Debt Current
LongTermDebtCurrent
17974000 usd
CY2024Q1 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
814442000 usd
CY2023Q4 us-gaap Long Term Debt Noncurrent
LongTermDebtNoncurrent
812068000 usd
CY2024Q1 rdnt Share Based Compensation Arrangement By Share Based Payment Award Number Of Plans
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfPlans
1 incentiveplan
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
20100000 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingNumber
911411 shares
CY2023Q4 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingWeightedAverageExercisePrice
16.60
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Grants In Period Gross
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsGrantsInPeriodGross
0 shares
CY2024Q1 us-gaap Share Based Compensation Arrangements By Share Based Payment Award Options Grants In Period Weighted Average Exercise Price
ShareBasedCompensationArrangementsByShareBasedPaymentAwardOptionsGrantsInPeriodWeightedAverageExercisePrice
0
CY2024Q1 us-gaap Stock Issued During Period Shares Stock Options Exercised
StockIssuedDuringPeriodSharesStockOptionsExercised
1000 shares
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Outstanding Weighted Average Remaining Contractual Term2
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsOutstandingWeightedAverageRemainingContractualTerm2
P5Y11M4D
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Outstanding Intrinsic Value
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsOutstandingIntrinsicValue
29178798000 usd
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Number
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableNumber
789112 shares
CY2024Q1 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Options Exercisable Weighted Average Exercise Price
ShareBasedCompensationArrangementByShareBasedPaymentAwardOptionsExercisableWeightedAverageExercisePrice
15.83
CY2024Q1 us-gaap Sharebased Compensation Shares Authorized Under Stock Option Plans Exercise Price Range Exercisable Options Weighted Average Remaining Contractual Term2
SharebasedCompensationSharesAuthorizedUnderStockOptionPlansExercisePriceRangeExercisableOptionsWeightedAverageRemainingContractualTerm2
P5Y6M10D
CY2024Q1 us-gaap Sharebased Compensation Arrangement By Sharebased Payment Award Options Exercisable Intrinsic Value1
SharebasedCompensationArrangementBySharebasedPaymentAwardOptionsExercisableIntrinsicValue1
25907138000 usd
CY2023Q2 us-gaap Share Based Compensation Arrangement By Share Based Payment Award Number Of Shares Authorized
ShareBasedCompensationArrangementByShareBasedPaymentAwardNumberOfSharesAuthorized
20100000 shares
CY2024Q1 us-gaap Deferred Compensation Arrangement With Individual Common Stock Reserved For Future Issuance
DeferredCompensationArrangementWithIndividualCommonStockReservedForFutureIssuance
3323670 shares
CY2024Q1 ecd Non Rule10b51 Arr Adopted Flag
NonRule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Adopted Flag
Rule10b51ArrAdoptedFlag
false
CY2024Q1 ecd Rule10b51 Arr Trmntd Flag
Rule10b51ArrTrmntdFlag
false
CY2024Q1 ecd Non Rule10b51 Arr Trmntd Flag
NonRule10b51ArrTrmntdFlag
false

Files In Submission

Name View Source Status
FilingSummary.xml Edgar Link unprocessable
rdnt-20240331_cal.xml Edgar Link unprocessable
0001628280-24-022619-index-headers.html Edgar Link pending
0001628280-24-022619-index.html Edgar Link pending
0001628280-24-022619.txt Edgar Link pending
0001628280-24-022619-xbrl.zip Edgar Link pending
Financial_Report.xlsx Edgar Link pending
MetaLinks.json Edgar Link pending
q12024exhibit311.htm Edgar Link pending
q12024exhibit312.htm Edgar Link pending
q12024exhibit321.htm Edgar Link pending
q12024exhibit322.htm Edgar Link pending
R1.htm Edgar Link pending
R10.htm Edgar Link pending
R11.htm Edgar Link pending
R12.htm Edgar Link pending
R13.htm Edgar Link pending
R14.htm Edgar Link pending
R15.htm Edgar Link pending
R16.htm Edgar Link pending
R17.htm Edgar Link pending
R18.htm Edgar Link pending
R19.htm Edgar Link pending
R2.htm Edgar Link pending
R20.htm Edgar Link pending
R21.htm Edgar Link pending
R22.htm Edgar Link pending
R23.htm Edgar Link pending
R24.htm Edgar Link pending
R25.htm Edgar Link pending
R26.htm Edgar Link pending
R27.htm Edgar Link pending
R28.htm Edgar Link pending
R29.htm Edgar Link pending
R3.htm Edgar Link pending
R30.htm Edgar Link pending
R31.htm Edgar Link pending
R32.htm Edgar Link pending
R33.htm Edgar Link pending
R34.htm Edgar Link pending
R35.htm Edgar Link pending
R36.htm Edgar Link pending
R37.htm Edgar Link pending
R38.htm Edgar Link pending
R39.htm Edgar Link pending
R4.htm Edgar Link pending
R40.htm Edgar Link pending
R41.htm Edgar Link pending
R42.htm Edgar Link pending
R43.htm Edgar Link pending
R44.htm Edgar Link pending
R45.htm Edgar Link pending
R46.htm Edgar Link pending
R47.htm Edgar Link pending
R5.htm Edgar Link pending
R6.htm Edgar Link pending
R7.htm Edgar Link pending
R8.htm Edgar Link pending
R9.htm Edgar Link pending
rdnt-20240331.htm Edgar Link pending
rdnt-20240331.xsd Edgar Link pending
report.css Edgar Link pending
Show.js Edgar Link pending
rdnt-20240331_def.xml Edgar Link unprocessable
rdnt-20240331_lab.xml Edgar Link unprocessable
rdnt-20240331_pre.xml Edgar Link unprocessable
rdnt-20240331_htm.xml Edgar Link completed